Focusing on decontamination of all patients in a hospital who may be at risk of suffering a hospital-acquired infection, and not just those who test positive for the MRSA superbug may help bring down overall hospital-acquired infections rates and MRSA infection rates within the facility.
That interesting new revelation came via a study published recently by the New England Journal of Medicine, and flies in the face of current recommendations by the US Centers For Disease Control And Prevention. The federal recommendations focus on testing of all incoming patients for MRSA and isolating the ones who have been contaminated by the superbug.
The research was based on a study of 74,250 patients. According to the researchers, patients in an ICU are already at a much higher risk of infection, and therefore, it makes sense to give everybody the anti-infection treatment, and not just those who have been detected with the MRSA superbug. The use of antibacterial soap and other measures to treat all patients in an intensive care unit, and not just those who test positive can help reduce MRSA infections.
The researchers found in their studies that such all-inclusive strategies that focused on all patients reduced MRSA infections by as much as 37%, while the risk of bloodstream infections dropped by 44%. The research found that the strategy was not only beneficial in terms of reducing the number of MRSA infections, but also in terms of reducing the number of infections overall in an ICU.
The researchers divided the hospitals into three separate groups. The first group consisted of ICUs that screened and isolated people who tested positive for the superbug. The second group also isolated patients who tested positive for the MRSA superbug, and used additional measures to clean individuals testing positive for the superbug by using a chlorhexidin solutione. The patients were also given a five-day antibiotic treatment consisting of mupirocin . In the third group, there was no separate screening or isolation of patient with MRSA, and all the ICU patients were given the chlorhexidine antiseptic wash as well as the mupirocin antibiotic therapy.
The researchers found that in the third group, there was a significant reduction in the MRSA infections. In fact, this was the only group that reported a substantial reduction in the number of these superbug infections. There was also a significant reduction in the number of bloodstream infections in this group.
The researchers were so encouraged by the findings of the study that they now recommend that hospitals eliminate protocols of the screening and isolation for MRSA patients that are currently in place at hospitals. They propose instead that hospitals include all patients in decontamination procedures.
The Indiana medical malpractice lawyers at Montross Miller Muller Mendelson Kennedy LLP, represent persons injured due to medical negligence across Indiana.